Medical Hyperspectral Imaging Systems Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Medical hyperspectral imaging systems (HIS) helps to identify materials, locate objects, detecting materials or surveillance by processing and collecting information from across the electromagnetic spectrum. Hyperspectral cameras combine the digital imaging technique with spectroscopy. Medical hyperspectral imaging is widely used for agriculture land inspection, geological, forestry, mineral exploration, food surface inspection, chemical analysis, and defense and military surveillance sectors (in unmanned aerial vehicle).
MARKET DYNAMICS
Medical hyperspectral imaging cameras provides highly consistent and accurate data for government, agricultural and military end users. Medical hyperspectral imaging systems market is anticipated to grow in the forecast period owing to driving factors such as rising demand for advanced medical hyperspectral imaging cameras, rising investment from private players in the field of medical hyperspectral imaging system, advancement in hyperspectral cameras used in medical applications. However, high cost of hyperspectral cameras may act as restraining factor.
MARKET SCOPE
The "Global Hyperspectral Imaging Systems Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of medical hyperspectral imaging systems market with detailed market segmentation by product, application, and geography. The global medical hyperspectral imaging systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading medical hyperspectral imaging systems market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global medical hyperspectral imaging systems market is segmented on the basis of product and end user. Based on product, the market is segmented as Cameras and accessories. On the basis of end user, the global medical hyperspectral imaging systems market is segmented into hospitals, diagnostic centers, specialty clinics and research centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global medical hyperspectral imaging systems market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The medical hyperspectral imaging systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting medical hyperspectral imaging systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the medical hyperspectral imaging systems market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global medical hyperspectral imaging systems market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The medical hyperspectral imaging systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting medical hyperspectral imaging systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the medical hyperspectral imaging systems market in these regions.
MARKET PLAYERS
The reports cover key developments in the medical hyperspectral imaging systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from medical hyperspectral imaging systems market are anticipated to lucrative growth opportunities in the future with the rising demand for medical hyperspectral imaging systems in the global market. Below mentioned is the list of few companies engaged in the medical hyperspectral imaging systems market.
The report also includes the profiles of key medical hyperspectral imaging systems market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- IMEC
- BaySpec, Inc.
- Corning Incorporated
- Headwall Photonics Inc.
- Norsk Elektro Optikk AS (NEO)
- Specim, Spectral Imaging Ltd.
- Surface Optics Corporation
- Telops Inc.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Medical Hyperspectral Imaging Systems - By Product
1.3.2 Medical Hyperspectral Imaging Systems - By End user
1.3.3 Medical Hyperspectral Imaging Systems - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - GLOBAL MARKET ANALYSIS
6.1. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - GLOBAL MARKET OVERVIEW
6.2. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CAMERAS
7.3.1. Overview
7.3.2. Cameras Market Forecast and Analysis
7.4. ACCESSORIES
7.4.1. Overview
7.4.2. Accessories Market Forecast and Analysis
8. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS - REVENUE AND FORECASTS TO 2028 – END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. DIAGNOSTIC CENTERS
8.4.1. Overview
8.4.2. Diagnostic Centers Market Forecast and Analysis
8.5. SPECIALTY CLINICS
8.5.1. Overview
8.5.2. Specialty Clinics Market Forecast and Analysis
8.6. RESEARCH CENTERS
8.6.1. Overview
8.6.2. Research Centers Market Forecast and Analysis
9. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Medical Hyperspectral Imaging Systems Overview
9.1.2 North America Medical Hyperspectral Imaging Systems Forecasts and Analysis
9.1.3 North America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Product
9.1.4 North America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By End user
9.1.5 North America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Countries
9.1.5.1 United States Medical Hyperspectral Imaging Systems
9.1.5.1.1 United States Medical Hyperspectral Imaging Systems by Product
9.1.5.1.2 United States Medical Hyperspectral Imaging Systems by End user
9.1.5.2 Canada Medical Hyperspectral Imaging Systems
9.1.5.2.1 Canada Medical Hyperspectral Imaging Systems by Product
9.1.5.2.2 Canada Medical Hyperspectral Imaging Systems by End user
9.1.5.3 Mexico Medical Hyperspectral Imaging Systems
9.1.5.3.1 Mexico Medical Hyperspectral Imaging Systems by Product
9.1.5.3.2 Mexico Medical Hyperspectral Imaging Systems by End user
9.2. EUROPE
9.2.1 Europe Medical Hyperspectral Imaging Systems Overview
9.2.2 Europe Medical Hyperspectral Imaging Systems Forecasts and Analysis
9.2.3 Europe Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Product
9.2.4 Europe Medical Hyperspectral Imaging Systems Forecasts and Analysis - By End user
9.2.5 Europe Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Countries
9.2.5.1 Germany Medical Hyperspectral Imaging Systems
9.2.5.1.1 Germany Medical Hyperspectral Imaging Systems by Product
9.2.5.1.2 Germany Medical Hyperspectral Imaging Systems by End user
9.2.5.2 France Medical Hyperspectral Imaging Systems
9.2.5.2.1 France Medical Hyperspectral Imaging Systems by Product
9.2.5.2.2 France Medical Hyperspectral Imaging Systems by End user
9.2.5.3 Italy Medical Hyperspectral Imaging Systems
9.2.5.3.1 Italy Medical Hyperspectral Imaging Systems by Product
9.2.5.3.2 Italy Medical Hyperspectral Imaging Systems by End user
9.2.5.4 Spain Medical Hyperspectral Imaging Systems
9.2.5.4.1 Spain Medical Hyperspectral Imaging Systems by Product
9.2.5.4.2 Spain Medical Hyperspectral Imaging Systems by End user
9.2.5.5 United Kingdom Medical Hyperspectral Imaging Systems
9.2.5.5.1 United Kingdom Medical Hyperspectral Imaging Systems by Product
9.2.5.5.2 United Kingdom Medical Hyperspectral Imaging Systems by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Medical Hyperspectral Imaging Systems Overview
9.3.2 Asia-Pacific Medical Hyperspectral Imaging Systems Forecasts and Analysis
9.3.3 Asia-Pacific Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Medical Hyperspectral Imaging Systems Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Countries
9.3.5.1 Australia Medical Hyperspectral Imaging Systems
9.3.5.1.1 Australia Medical Hyperspectral Imaging Systems by Product
9.3.5.1.2 Australia Medical Hyperspectral Imaging Systems by End user
9.3.5.2 China Medical Hyperspectral Imaging Systems
9.3.5.2.1 China Medical Hyperspectral Imaging Systems by Product
9.3.5.2.2 China Medical Hyperspectral Imaging Systems by End user
9.3.5.3 India Medical Hyperspectral Imaging Systems
9.3.5.3.1 India Medical Hyperspectral Imaging Systems by Product
9.3.5.3.2 India Medical Hyperspectral Imaging Systems by End user
9.3.5.4 Japan Medical Hyperspectral Imaging Systems
9.3.5.4.1 Japan Medical Hyperspectral Imaging Systems by Product
9.3.5.4.2 Japan Medical Hyperspectral Imaging Systems by End user
9.3.5.5 South Korea Medical Hyperspectral Imaging Systems
9.3.5.5.1 South Korea Medical Hyperspectral Imaging Systems by Product
9.3.5.5.2 South Korea Medical Hyperspectral Imaging Systems by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Medical Hyperspectral Imaging Systems Overview
9.4.2 Middle East and Africa Medical Hyperspectral Imaging Systems Forecasts and Analysis
9.4.3 Middle East and Africa Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Medical Hyperspectral Imaging Systems Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Countries
9.4.5.1 South Africa Medical Hyperspectral Imaging Systems
9.4.5.1.1 South Africa Medical Hyperspectral Imaging Systems by Product
9.4.5.1.2 South Africa Medical Hyperspectral Imaging Systems by End user
9.4.5.2 Saudi Arabia Medical Hyperspectral Imaging Systems
9.4.5.2.1 Saudi Arabia Medical Hyperspectral Imaging Systems by Product
9.4.5.2.2 Saudi Arabia Medical Hyperspectral Imaging Systems by End user
9.4.5.3 U.A.E Medical Hyperspectral Imaging Systems
9.4.5.3.1 U.A.E Medical Hyperspectral Imaging Systems by Product
9.4.5.3.2 U.A.E Medical Hyperspectral Imaging Systems by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Medical Hyperspectral Imaging Systems Overview
9.5.2 South and Central America Medical Hyperspectral Imaging Systems Forecasts and Analysis
9.5.3 South and Central America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Product
9.5.4 South and Central America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By End user
9.5.5 South and Central America Medical Hyperspectral Imaging Systems Forecasts and Analysis - By Countries
9.5.5.1 Brazil Medical Hyperspectral Imaging Systems
9.5.5.1.1 Brazil Medical Hyperspectral Imaging Systems by Product
9.5.5.1.2 Brazil Medical Hyperspectral Imaging Systems by End user
9.5.5.2 Argentina Medical Hyperspectral Imaging Systems
9.5.5.2.1 Argentina Medical Hyperspectral Imaging Systems by Product
9.5.5.2.2 Argentina Medical Hyperspectral Imaging Systems by End user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. MEDICAL HYPERSPECTRAL IMAGING SYSTEMS, KEY COMPANY PROFILES
11.1. IMEC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYSPEC, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CORNING INCORPORATED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HEADWALL PHOTONICS INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NORSK ELEKTRO OPTIKK AS (NEO)
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SPECIM, SPECTRAL IMAGING LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SURFACE OPTICS CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TELOPS INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- IMEC
- BaySpec, Inc.
- Corning Incorporated
- Headwall Photonics Inc.
- Norsk Elektro Optikk AS (NEO)
- Specim, Spectral Imaging Ltd.
- Surface Optics Corporation
- Telops Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.